The Allstate Co. (NYSE:ALL – Get Free Report) saw a significant decrease in short interest in October. As of October 31st, there was short interest totalling 1,960,000 shares, a decrease of 11.3% from the October 15th total of 2,210,000 shares. Based on an average daily volume of 1,500,000 shares, the short-interest ratio is currently 1.3 days. Approximately 0.7% of the shares of the stock are short sold.
Insider Transactions at Allstate
In other news, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares in the company, valued at $15,880,915.68. This represents a 50.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 57.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.80% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. BDF Gestion purchased a new stake in Allstate during the 2nd quarter valued at about $3,051,000. OFI Invest Asset Management purchased a new stake in shares of Allstate in the second quarter worth about $476,000. Cetera Investment Advisers increased its holdings in shares of Allstate by 351.6% during the 1st quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock valued at $11,284,000 after purchasing an additional 50,780 shares in the last quarter. Diversified Trust Co lifted its stake in shares of Allstate by 505.3% in the 2nd quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock valued at $1,265,000 after purchasing an additional 6,614 shares during the period. Finally, Canada Pension Plan Investment Board boosted its stake in shares of Allstate by 97.5% during the 1st quarter. Canada Pension Plan Investment Board now owns 271,464 shares of the insurance provider’s stock worth $46,966,000 after acquiring an additional 134,028 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Allstate Trading Down 1.1 %
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm’s revenue for the quarter was up 14.7% on a year-over-year basis. During the same quarter last year, the business posted $0.81 EPS. As a group, sell-side analysts expect that Allstate will post 16.01 EPS for the current fiscal year.
Allstate Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.86%. The ex-dividend date is Friday, November 29th. Allstate’s dividend payout ratio (DPR) is presently 23.83%.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on ALL shares. Raymond James raised their target price on Allstate from $205.00 to $220.00 and gave the stock a “strong-buy” rating in a research report on Friday, October 4th. BMO Capital Markets increased their target price on shares of Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Roth Mkm reaffirmed a “buy” rating and issued a $200.00 price target on shares of Allstate in a research note on Wednesday, August 14th. JPMorgan Chase & Co. increased their price target on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Finally, Morgan Stanley boosted their price target on shares of Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a research note on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Allstate has a consensus rating of “Moderate Buy” and a consensus target price of $214.19.
View Our Latest Stock Report on ALL
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- Dividend Payout Ratio Calculator
- 3 Hot Stock Trends to Ride Into 2025
- What does consumer price index measure?
- Arm Holdings: Buy the Dip or Wait for a Better Price?
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why Alphabet Stock Dips Are the Perfect Time to Invest
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.